• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

哮喘微生物组研究与新治疗策略的潜力。

Asthma microbiome studies and the potential for new therapeutic strategies.

机构信息

Division of Pulmonary, Critical Care, Allergy, and Sleep Medicine, University of California San Francisco, 505 Parnassus Avenue, Box 0130, San Francisco, CA, 94143-0130, USA,

出版信息

Curr Allergy Asthma Rep. 2013 Oct;13(5):453-61. doi: 10.1007/s11882-013-0355-y.

DOI:10.1007/s11882-013-0355-y
PMID:23709178
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3778058/
Abstract

Recent applications of culture-independent tools for microbiome profiling have revealed significant relationships between asthma and microbiota associated with the environment, gut, or airways. Studies of the airway microbiome in particular represent a new frontier in pulmonary research. Although these studies are relatively new, current evidence suggests the possibility of new therapeutic strategies for the treatment or prevention of asthma. In this article, recent literature on microbiota and asthma are critically reviewed, with a particular focus on studies of the airway microbiome. Perspectives are presented on how growing knowledge of relationships between the microbiome and asthma is likely to translate into improved understanding of asthma pathogenesis, its heterogeneity, and opportunities for novel treatment approaches.

摘要

最近,非培养工具在微生物组分析中的应用揭示了哮喘与环境、肠道或气道相关的微生物群之间的显著关系。特别是气道微生物组的研究代表了肺部研究的一个新领域。尽管这些研究相对较新,但目前的证据表明,可能有新的治疗策略可用于治疗或预防哮喘。本文批判性地回顾了关于微生物组和哮喘的最新文献,特别关注气道微生物组的研究。本文还提出了这样一种观点,即对微生物组和哮喘之间关系的认识不断增加,很可能会促进对哮喘发病机制、异质性以及新型治疗方法的机会的深入理解。

相似文献

1
Asthma microbiome studies and the potential for new therapeutic strategies.哮喘微生物组研究与新治疗策略的潜力。
Curr Allergy Asthma Rep. 2013 Oct;13(5):453-61. doi: 10.1007/s11882-013-0355-y.
2
The Potential for Emerging Microbiome-Mediated Therapeutics in Asthma.新兴的微生物群介导的哮喘治疗方法的潜力
Curr Allergy Asthma Rep. 2017 Aug 10;17(9):62. doi: 10.1007/s11882-017-0730-1.
3
The microbiome in asthma.哮喘中的微生物群
J Allergy Clin Immunol. 2015 Jan;135(1):25-30. doi: 10.1016/j.jaci.2014.11.011.
4
Potential Role of the Lung Microbiome in Shaping Asthma Phenotypes.肺部微生物组在塑造哮喘表型中的潜在作用。
Ann Am Thorac Soc. 2017 Nov;14(Supplement_5):S326-S331. doi: 10.1513/AnnalsATS.201702-138AW.
5
Influence and effect of the human microbiome in allergy and asthma.人类微生物群在过敏和哮喘中的影响及作用。
Curr Opin Rheumatol. 2015 Jul;27(4):373-80. doi: 10.1097/BOR.0000000000000191.
6
The Role of Lung and Gut Microbiota in the Pathology of Asthma.肺部和肠道微生物群在哮喘发病机制中的作用。
Immunity. 2020 Feb 18;52(2):241-255. doi: 10.1016/j.immuni.2020.01.007.
7
The Lung Microbiome and Airway Disease.肺部微生物群与气道疾病
Ann Am Thorac Soc. 2016 Dec;13 Suppl 2(Suppl 5):S462-S465. doi: 10.1513/AnnalsATS.201605-356AW.
8
Influences of the microbiome on the early origins of allergic asthma.微生物组对过敏性哮喘早期发病的影响。
Ann Am Thorac Soc. 2013 Dec;10 Suppl:S165-9. doi: 10.1513/AnnalsATS.201305-118AW.
9
Does IL-17 Respond to the Disordered Lung Microbiome and Contribute to the Neutrophilic Phenotype in Asthma?白细胞介素-17是否对紊乱的肺部微生物群有反应并促成哮喘中的中性粒细胞表型?
Mediators Inflamm. 2016;2016:6470364. doi: 10.1155/2016/6470364. Epub 2016 Jan 28.
10
Microbiome in the primary prevention of allergic diseases and bronchial asthma.微生物群在过敏性疾病和支气管哮喘的一级预防中的作用
Allergol Immunopathol (Madr). 2019 Jan-Feb;47(1):79-84. doi: 10.1016/j.aller.2018.03.005. Epub 2018 Jul 3.

引用本文的文献

1
Gut microbiota dysbiosis and its impact on asthma and other lung diseases: potential therapeutic approaches.肠道微生物失调及其对哮喘和其他肺部疾病的影响:潜在的治疗方法。
Korean J Intern Med. 2024 Sep;39(5):746-758. doi: 10.3904/kjim.2023.451. Epub 2024 Aug 30.
2
Lung microbiome: new insights into the pathogenesis of respiratory diseases.肺部微生物组:呼吸系统疾病发病机制的新见解。
Signal Transduct Target Ther. 2024 Jan 17;9(1):19. doi: 10.1038/s41392-023-01722-y.
3
Gut microbiota-related metabolite alpha-linolenic acid mitigates intestinal inflammation induced by oral infection with Toxoplasma gondii.

本文引用的文献

1
Neonatal supplementation of processed supernatant from Lactobacillus rhamnosus GG improves allergic airway inflammation in mice later in life.鼠李糖乳杆菌 GG 发酵上清液对新生期小鼠的补充可改善其生命后期的过敏性气道炎症。
Clin Exp Allergy. 2013 Mar;43(3):353-64. doi: 10.1111/cea.12047.
2
Differences in fungi present in induced sputum samples from asthma patients and non-atopic controls: a community based case control study.哮喘患者和非特应性对照者诱导痰样本中真菌的差异:基于社区的病例对照研究。
BMC Infect Dis. 2013 Feb 5;13:69. doi: 10.1186/1471-2334-13-69.
3
Farm exposure and time trends in early childhood may influence DNA methylation in genes related to asthma and allergy.
肠道微生物相关代谢产物α-亚麻酸可减轻弓形虫口服感染引起的肠道炎症。
Microbiome. 2023 Dec 12;11(1):273. doi: 10.1186/s40168-023-01681-0.
4
MADGAN:A microbe-disease association prediction model based on generative adversarial networks.MADGAN:一种基于生成对抗网络的微生物-疾病关联预测模型。
Front Microbiol. 2023 Mar 23;14:1159076. doi: 10.3389/fmicb.2023.1159076. eCollection 2023.
5
An Overview on the Primary Factors That Contribute to Non-Allergic Asthma in Children.儿童非过敏性哮喘主要影响因素概述
J Clin Med. 2022 Nov 5;11(21):6567. doi: 10.3390/jcm11216567.
6
Holy Grail: the journey towards disease modification in asthma.圣杯:哮喘疾病修饰治疗之路。
Eur Respir Rev. 2022 Feb 22;31(163). doi: 10.1183/16000617.0183-2021. Print 2022 Mar 31.
7
Interactions between NCRILC3s and the Microbiome in the Airways Shape Asthma Severity.气道中NCRILC3与微生物群之间的相互作用影响哮喘严重程度。
Immune Netw. 2021 Jul 22;21(4):e25. doi: 10.4110/in.2021.21.e25. eCollection 2021 Aug.
8
Inflammatory Endotype-associated Airway Microbiome in Chronic Obstructive Pulmonary Disease Clinical Stability and Exacerbations: A Multicohort Longitudinal Analysis.慢性阻塞性肺疾病临床稳定期和加重期的炎症表型相关气道微生物组:一项多队列纵向分析。
Am J Respir Crit Care Med. 2021 Jun 15;203(12):1488-1502. doi: 10.1164/rccm.202009-3448OC.
9
Alteration of Lung and Gut Microbiota in IL-13-Transgenic Mice Simulating Chronic Asthma.模拟慢性哮喘的 IL-13 转基因小鼠的肺和肠道微生物组的改变。
J Microbiol Biotechnol. 2020 Dec 28;30(12):1819-1826. doi: 10.4014/jmb.2009.09019.
10
Role of Lung Microbiome in Innate Immune Response Associated With Chronic Lung Diseases.肺部微生物群在与慢性肺部疾病相关的固有免疫反应中的作用。
Front Med (Lausanne). 2020 Sep 18;7:554. doi: 10.3389/fmed.2020.00554. eCollection 2020.
儿童早期的农场暴露和时间趋势可能会影响与哮喘和过敏相关的基因的 DNA 甲基化。
Allergy. 2013 Mar;68(3):355-64. doi: 10.1111/all.12097. Epub 2013 Jan 25.
4
Asthma-associated differences in microbial composition of induced sputum.诱导痰微生物组成与哮喘的相关性差异。
J Allergy Clin Immunol. 2013 Feb;131(2):346-52.e1-3. doi: 10.1016/j.jaci.2012.11.013. Epub 2012 Dec 23.
5
Use of antibiotics during pregnancy increases the risk of asthma in early childhood.孕期使用抗生素会增加儿童早期患哮喘的风险。
J Pediatr. 2013 Apr;162(4):832-838.e3. doi: 10.1016/j.jpeds.2012.09.049. Epub 2012 Nov 6.
6
Environmental bacteria and childhood asthma.环境细菌与儿童哮喘。
Allergy. 2012 Dec;67(12):1565-71. doi: 10.1111/all.12028. Epub 2012 Sep 21.
7
Does pet ownership in infancy lead to asthma or allergy at school age? Pooled analysis of individual participant data from 11 European birth cohorts.婴儿时期是否拥有宠物会导致学龄期哮喘或过敏?11 个欧洲出生队列的个体参与者数据汇总分析。
PLoS One. 2012;7(8):e43214. doi: 10.1371/journal.pone.0043214. Epub 2012 Aug 29.
8
High-throughput bacterial genome sequencing: an embarrassment of choice, a world of opportunity.高通量细菌基因组测序:选择之多令人尴尬,机会之广蔚为大观。
Nat Rev Microbiol. 2012 Sep;10(9):599-606. doi: 10.1038/nrmicro2850. Epub 2012 Aug 6.
9
Immunomodulatory effects of feeding with Bifidobacterium longum on allergen-induced lung inflammation in the mouse.长双歧杆菌喂养对小鼠变应原诱导的肺部炎症的免疫调节作用。
Pulm Pharmacol Ther. 2012 Aug;25(4):325-34. doi: 10.1016/j.pupt.2012.05.011. Epub 2012 Jun 13.
10
Oral administration of Enterococcus faecalis FK-23 suppresses Th17 cell development and attenuates allergic airway responses in mice.口服屎肠球菌 FK-23 抑制小鼠 Th17 细胞的发育并减轻过敏性气道反应。
Int J Mol Med. 2012 Aug;30(2):248-54. doi: 10.3892/ijmm.2012.1010. Epub 2012 May 24.